- IMS Info Brochure (pdf)We Extend the Frontiers (pdf)Patient information (pdf)Second Opinion (pdf)Check ups (pdf)
News
Important! Please Note Our Changed Email Address! [29.08.2022]
Dear patients and colleagues, Our general IMS email has been changed.
Charity Concert in Support of Ukraine [16.08.2022]
The Medical Center – University of Freiburg is expressing support for Ukraine by organizing a charity concert on Sunday, 21 August 2022 at 3 pm in the Church of the Holy Spirit on the hospital premises.
Therapy with CAR-T Cells for Lymphoma and Leukemia [02.08.2022]
In the treatment of uncontrolled types of lymphoma and leukemia, CAR-T cell therapy offers an innovative therapeutic approach with new chances of recovery.
Modern Therapies for Prostate Cancer [01.07.2022]
Prostate cancer is the most common tumor in men and is more likely to occur with increasing age. But thanks to innovative therapy methods, chances of recovery are good. At the Medical Center – University of Freiburg, doctors and researchers fight prostate cancer with everything that modern medicine has to offer.
New Medical Director for the Department of Neuropediatrics and Muscle Disorders [28.05.2022]
Prof. Dr. Janbernd Kirschner focuses on neuromuscular hereditary diseases with a mostly severe course as well as on testing of innovative therapies for rare diseases.
Online Consultations with a Doctor Offer Essential Benefits [20.04.2022]
Rapid and remote: the pandemic has boosted telemedical services all over the world. They have been used, among other things, for online medical consultations.
Treatment of Laryngeal Carcinoma [28.03.2022]
The Department of Oto-Rhino-Laryngology of the Medical Center - University of Freiburg has by far the greatest operational expertise of all 63 centers in Germany.
Medical Assistance to Ukraine from the Medical Center - University of Freiburg: Coordination through IMS [04.03.2022]
Various support measures for Ukraine are centrally coordinated by International Medical Services / A donation account is set up
Aquablation® Therapy in the Treatment of Prostate Adenoma [18.02.2022]
Applying this procedure presents a lower rate of complications and less side effects on sexual activity.
Freiburg Expert Answers Questions about Omicron [21.01.2022]
Prof. Dr. Siegbert Richard Rieg – Director of the of the Division of Infectious Diseases at the Department of Gastroenterology, Hepatology, Endocrinology and Infectious Diseases at the Medical Center - University of Freiburg – spoke with us about the COVID-19 variant